Form 4 for MRNA Moderna
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-06 · accession 0001127602-25-017073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-09 | 2025-06-06 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $26.12 | -551 | 27.5K | -2% | -$14.4K |
| D | 2025-06-09 | 2025-06-06 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,139 | 28.0K | +4% | — |
| D | 2025-06-09 | 2025-06-06 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -1,139 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-06 | F | D | 551 | $26.12 | 27,483 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-06 | M | A | 1,139 | — | 28,034 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) Includes 595 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 30, 2025. |
| 3 | Derivative | Restricted Stock Units | 2025-06-06 | M | D | 1,139 | $0.00 | 0 | D | — · — to — | 1,139 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. This restricted stock unit award is fully vested as of June 6, 2025. |